Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Noviral Sweden AB
AB
Active
Org 5591757942
Humlegårdsgatan 4, 114 46
Stockholm
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2018
1-4 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Noviral Sweden AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
OP
Oskar Peder Holger Strålin
Chief Auditor
Chief Auditor
2025
CG
Carl Gustaf Anders Cederström
Authorized Recipient of Service
Authorized Recipient of Service
2025
Former (5)
CE
Christoffer Erik Sillén
Audit
Audit
2020 – 2025
PH
Pär Henrik Rouet-Leduc
Chief Executive Officer
Chief Executive Officer
2021 – 2022
EM
Erik Mikael Jämtberg
Chief Executive Officer
Chief Executive Officer
2023 – 2023
JS
Jessica Sofia Margaretha Leijon
Chief Executive Officer
Chief Executive Officer
2022 – 2025
MJ
Maria Jesus Canal De Kempe
Chief Executive Officer
Chief Executive Officer
2021 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
CM
Claudia Maria Jesus Helfrid L Kempe
Board of Directors
2025
PC
Patrik Carlos Gerhard Kempe
Board of Directors
2021
AJ
Alexander Johan Carl Kempe
Chairman
2022
Former (4)
JÅ
Johanna Åsa Livijn
Board of Directors
2020 – 2021
AS
Anna Sara Mathilda Arned Nord
Chairman
2020 – 2021
DG
David Gustaf Nord
Chairman
2021 – 2022
LC
Linda Chun Zhou
Board of Directors
2020 – 2021
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Novir AB
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Noviral Sweden AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network